Interferon-beta 1a in relapsing-remitting multiple sclerosis. First report of a Mexican population;El interferón-beta la en el tratamiento de la esclerosis múltiple con curso remitente-recurrente. Primera descripción en una población Mexicana

Revista de Neurologia

Volumn 31, Issue 11, 2000, Pages 1019-1022

  Leon C ^a   Violante, A ^a   Arriada, N ^a   Santana, H R ^a   Corona, T ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Gender; Interferon beta 1a; Mexican; Multiple sclerosis; Population; Report

Indexed keywords

BETA1 INTERFERON; BETA1A INTERFERON; LIVER ENZYME;

ADOLESCENT; ADULT; ANAPHYLACTIC SHOCK; ANEMIA; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DISEASE COURSE; FATIGUE; FEMALE; FOLLOW UP; GENDER; HEADACHE; HUMAN; LEUKOPENIA; MALE; MEXICO; MULTIPLE SCLEROSIS; MYALGIA; RECURRENT DISEASE; SOMNOLENCE; TREATMENT FAILURE;

EID: 0034483148     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3111.2000347     Document Type: Article

References (38)

1. The epidemiology of multiple sclerosis
2. A repetitive DNA sequence 5′ to the human myelin basic protein gene may be linked to MS in Danes
3. Review: Cytokines and the pathogenesis of multiple sclerosis
4. Stress proteins their role in the normal central nervous system and in disease states, especially multiple sclerosis
5. Immunology of multiple sclerosis
6. Is the frequency of multiple sclerosis increasing in Mexico?
7. Multiple sclerosis in Mexico: Hospital cases at the National Institute of Neurology and Neurosurgery, Mexico City
8. The natural history of multiple sclerosis: A geographical base study predictive value of the early clinical course
9. Multiple sclerosis presenting as transverse myelopathy: Clinical and MRI features
10. Fulminant multiple sclerosis
11. Management of multiple sclerosis
12. New treatments and azathioprine in multiple sclerosis
13. Copolymer 1: A most reasonable alternative therapy for early relapsing-remitting multiple sclerosis with mild disability
14. Multiple sclerosis. Therapeutic update
15. Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers
16. Interferons in multiple sclerosis: A review of the evidence
17. Recombinant beta-beta interferon inhibits gamma interferon production in multiple sclerosis
18. Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells: Implications for multiple sclerosis autoimmune diseases
19. Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid an transformed human cells
20. Interferon beta in the treatment of multiple sclerosis
21. Interferon beta-1b for multiple sclerosis
22. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis
23. Value of magnetic resonance imaging in assessing efficacy in clinical trials of multiple sclerosis therapies
24. The role of magnetic resonance techniques in understanding and managing multiple sclerosis
25. Magnetic resonance imaging changes with recombinant human interferon beta-1a: A short term study in relapsing-remitting multiple sclerosis
26. Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis
27. Recombinant human beta interferon treatment of relapsing-remitting multiple sclerosis: A pilot study
28. Consequences of magnetic relaxation coupling
29. Intramuscular interferon beta-1a for disease progression in relapsing-remitting multiple sclerosis
30. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
31. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
32. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: MRI results of a multicenter, randomized, double blind, placebo controlled trial
33. Assessment of MRI criteria for a diagnosis of multiple sclerosis
34. Severe anaphylaxis with recombinant interferon beta
35. Pearls and pitfalls of interferon beta treatment for multiple sclerosis
36. Hormonal effects on the immune system: Basic and clinical issues in multiple sclerosis